DELIVERY ORDER
Active75F40126F19024
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$712.7K
obligated · signed 2 months ago
EO 14398 - (PACS) IDIQ - REGULATORY REVIEW SUPPORT
Performance timeline
Start
Sep 30, 2026
End
Sep 29, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Sep 29, 2027
KAIVA STRATEGIES, LLC
Contract 75F40126F19024
UEI
HCWKVFGBPA64
Parent Company
KAIVA STRATEGIES, LLC
Capabilities & Certifications
Headquarters Location
Congressional District: 02
Current Obligation
$712,662
Base + Exercised Options
$712,662
Total Ceiling Value
$712,662
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
ADMINISTRATIVE MANAGEMENT AND GENERAL MANAGEMENT CONSULTING SERVICES
PSC
SUPPORT- PROFESSIONAL: OTHER
Place of Performance
Congressional District: 04
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Contract Vehicle
75F40123D00021
IDCDepartment of Health and Human Services
Award type: SINGLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.